Business Context and Reporting Period
This Form 8-K Current Report was filed by Gran Tierra Energy Inc. on February 3, 2012. The filing discloses executive compensation decisions approved by the Board of Directors on the same date, covering fiscal year 2011 performance bonuses, fiscal year 2012 base salaries and target bonuses, and new equity grants under the 2007 Equity Incentive Plan.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive compensation figures.
- 2011 Cash Bonuses: Total bonuses for Named Executive Officers (NEOs) ranged from approximately $63,578 USD (Acting CFO) to $195,925 USD (CEO).
- 2012 Base Salaries: Approved annual base salaries for NEOs range from approximately $225,313 USD (Acting CFO) to $416,340 USD (CEO).
- 2012 Target Bonuses: Set as a percentage of base salary, ranging from 60% to 80%.
- Equity Grants: Non-statutory stock options (NSOs) were granted to seven NEOs, totaling 1,040,000 shares. The CEO received 375,000 options, while other executives received between 35,000 and 275,000 options.
Material Changes
The filing details a change in the Chief Financial Officer (CFO) role. Martin Eden, the CFO, was placed on medical leave effective December 9, 2011, following emergency surgery. James Rozon was appointed Acting CFO and Principal Financial and Accounting Officer on that date. The compensation disclosed reflects Mr. Rozon's acting status and salary.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of general business risks. It notes specific contingencies regarding the equity grants:
- Grant Date: The grant date for the stock options is the third business day after the public release of annual revenues for the fiscal year ended December 31, 2011, unless the trading window is closed.
- Vesting: Options have a three-year vesting schedule, with one-third vesting annually.
- Exercise Price: To be determined on the grant date.
Investor Verification Checklist
- Verify the exact grant date and exercise price for the 1,040,000 stock options once the trading window opens.
- Confirm the duration of Martin Eden's medical leave and the timeline for his return or potential permanent replacement.
- Review the full 2011 Annual Report (10-K) for the underlying financial performance that justified the 2011 cash bonuses.
- Monitor the exchange rates used for converting Canadian dollars and Brazilian reals to USD, as these impact the reported compensation values.